|
Cardiovascular/ Cardiothoracic Surgery
Citations 91-100 of 222 total displayed.
|
Past content
(since Nov 1998):
|
- Letters
Efficacy and Safety of Edifoligide—Reply
- John H. Alexander; Robert A. Harrington; T. Bruce Ferguson; Eric D. Peterson; C. Michael Gibson; Nicholas T. Kouchoukos; for the PREVENT IV Investigators
JAMA 2006; 295: 1514-a-1515-a.
[Extract]
[Full text]
[PDF]
- Letters
Efficacy and Safety of Edifoligide
- Nimesh D. Desai; Stephen E. Fremes
JAMA 2006; 295: 1514.
[Extract]
[Full text]
[PDF]
- Original Contributions
Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial
- The OASIS-6 Trial Group*
JAMA 2006; 295: 1519-1530.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: The ISAR-REACT 2 Randomized Trial
- Adnan Kastrati; Julinda Mehilli; Franz-Josef Neumann; Franz Dotzer; Jurriën ten Berg; Hildegard Bollwein; Isolde Graf; Maryam Ibrahim; Jürgen Pache; Melchior Seyfarth; Helmut Schühlen; Josef Dirschinger; Peter B. Berger; Albert Schömig; for the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 (ISAR-REACT 2) Trial Investigators
JAMA 2006; 295: 1531-1538.
[Abstract]
[Full text]
[PDF]
- Editorials
Clopidogrel Treatment Prior to Percutaneous Coronary Intervention: When Enough Isn't Enough
- Steven R. Steinhubl; Richard Charnigo
JAMA 2006; 295: 1581-1582.
[Extract]
[Full text]
[PDF]
- Original Contributions
Paclitaxel-Eluting Stents vs Vascular Brachytherapy for In-Stent Restenosis Within Bare-Metal Stents: The TAXUS V ISR Randomized Trial
- Gregg W. Stone; Stephen G. Ellis; Charles D. O’Shaughnessy; Steven L. Martin; Lowell Satler; Thomas McGarry; Mark A. Turco; Dean J. Kereiakes; Lynne Kelley; Jeffrey J. Popma; Mary E. Russell; for the TAXUS V ISR Investigators
JAMA 2006; 295: 1253-1263.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Sirolimus-Eluting Stents vs Vascular Brachytherapy for In-Stent Restenosis Within Bare-Metal Stents: The SISR Randomized Trial
- David R. Holmes Jr; Paul Teirstein; Lowell Satler; Michael Sketch; James O’Malley; Jeffery J. Popma; Richard E. Kuntz; Peter J. Fitzgerald; Hong Wang; Eileen Caramanica; Sidney A. Cohen; for the SISR Investigators
JAMA 2006; 295: 1264-1273.
[Abstract]
[Full text]
[PDF]
- Editorials
Brachytherapy for In-Stent Restenosis: A Distant Second Choice to Drug-Eluting Stent Placement
- Debabrata Mukherjee; David J. Moliterno
JAMA 2006; 295: 1307-1309.
[Extract]
[Full text]
[PDF]
- Original Contributions
Sirolimus- vs Paclitaxel-Eluting Stents in De Novo Coronary Artery Lesions: The REALITY Trial: A Randomized Controlled Trial
- Marie-Claude Morice; Antonio Colombo; Bernhard Meier; Patrick Serruys; Corrado Tamburino; Giulio Guagliumi; Eduardo Sousa; Hans-Peter Stoll; for the REALITY Trial Investigators
JAMA 2006; 295: 895-904.
[Abstract]
[Full text]
[PDF]
- Editorials
Wish List and REALITY: Choice of Stents and End Points for Treatment of De Novo Coronary Artery Lesions
- Sorin J. Brener
JAMA 2006; 295: 937-938.
[Extract]
[Full text]
[PDF]
|
|
